Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

347 ARTÍCULOS , VIENDO DEL 286 AL 300

Antioxidant status and energy state of erythrocytes in Alzheimer dementia: probing for markers

Kosenko EA, Aliev G, Tikhonova LA, Li Y, Poghosyan AC, Kaminsky YG.

CNS Neurol Disord Drug Targets. 2012 Nov 1;11(7):926-32. doi: 10.2174/1871527311201070926.

Corticosteroids, but not NSAIDs, are associated with less Alzheimer neuropathology

Beeri MS, Schmeidler J, Lesser GT, Maroukian M, West R, Leung S, Wysocki M, Perl DP, Purohit DP, Haroutunian V.

Neurobiol Aging. 2012 Jul;33(7):1258-64. doi: 10.1016/j.neurobiolaging.2011.02.011. Epub 2011 Apr 1.

Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial

Leoutsakos JM, Muthen BO, Breitner JC, Lyketsos CG; ADAPT Research Team.

Int J Geriatr Psychiatry. 2012 Apr;27(4):364-74. doi: 10.1002/gps.2723. Epub 2011 May 10.

Do tocotrienols have potential as neuroprotective dietary factors?

Frank J, Chin XW, Schrader C, Eckert GP, Rimbach G.

Ageing Res Rev. 2012 Jan;11(1):163-80. doi: 10.1016/j.arr.2011.06.006. Epub 2011 Jul 7.

Dysfunction of TGF-β1 signaling in Alzheimer's disease: perspectives for neuroprotection

Caraci F, Spampinato S, Sortino MA, Bosco P, Battaglia G, Bruno V, Drago F, Nicoletti F, Copani A.

Cell Tissue Res. 2012 Jan;347(1):291-301. doi: 10.1007/s00441-011-1230-6. Epub 2011 Aug 31.

'Clinical trials in Alzheimer's disease': immunotherapy approaches

Delrieu J, Ousset PJ, Caillaud C, Vellas B.

J Neurochem. 2012 Jan;120 Suppl 1:186-193. doi: 10.1111/j.1471-4159.2011.07458.x. Epub 2011 Nov 28.

Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4

Chen S, Liu AR, An FM, Yao WB, Gao XD.

Age (Dordr). 2012 Oct;34(5):1211-24. doi: 10.1007/s11357-011-9303-8. Epub 2011 Sep 8.

Strategic role for mitochondria in Alzheimer's disease and cancer

Hedskog L, Zhang S, Ankarcrona M.

Antioxid Redox Signal. 2012 Jun 15;16(12):1476-91. doi: 10.1089/ars.2011.4259. Epub 2011 Oct 26.

Selective liver X receptor modulators (SLiMs): what use in human health?

Viennois E, Mouzat K, Dufour J, Morel L, Lobaccaro JM, Baron S.

Mol Cell Endocrinol. 2012 Apr 4;351(2):129-41. doi: 10.1016/j.mce.2011.08.036. Epub 2011 Sep 1.

Effect of vitamin E administration on the elevated oxygen stress and the telomeric and subtelomeric status in Alzheimer's disease

Guan JZ, Guan WP, Maeda T, Makino N.

Gerontology. 2012;58(1):62-9. doi: 10.1159/000327821. Epub 2011 Sep 7.

Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer's disease

Kume K, Hanyu H, Sakurai H, Takada Y, Onuma T, Iwamoto T.

Geriatr Gerontol Int. 2012 Apr;12(2):207-14. doi: 10.1111/j.1447-0594.2011.00746.x. Epub 2011 Sep 19.

New developments on the role of NMDA receptors in Alzheimer's disease

Malinow R.

Curr Opin Neurobiol. 2012 Jun;22(3):559-63. doi: 10.1016/j.conb.2011.09.001. Epub 2011 Sep 29.

A review of the effects of memantine on clinical progression in Alzheimer's disease

Wilkinson D.

Int J Geriatr Psychiatry. 2012 Aug;27(8):769-76. doi: 10.1002/gps.2788. Epub 2011 Oct 1.

Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease

Williams RJ, Spencer JP.

Free Radic Biol Med. 2012 Jan 1;52(1):35-45. doi: 10.1016/j.freeradbiomed.2011.09.010. Epub 2011 Sep 17.

Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab

Ostrowitzki S, Deptula D, Thurfjell L, Barkhof F, Bohrmann B, Brooks DJ, Klunk WE, Ashford E, Yoo K, Xu ZX, Loetscher H, Santarelli L.

Arch Neurol. 2012 Feb;69(2):198-207. doi: 10.1001/archneurol.2011.1538. Epub 2011 Oct 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias